This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Oncology  • Breast Cancer  • Women's Health  • Women's Health, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 132 words of the full text and any section headings.

To the Editor: It is possible that the results of the WHI investigation¹ may be explained in part by the action of estrogen on biological factors that increase breast cancer risk in postmenopausal women.² Oral estrogens, through their metabolic action, oppose insulin resistance. Furthermore, through their hepatocellular actions, they cause an increase in sex hormone–binding globulin level, and a decrease in insulin-like growth factor I (IGF-I) activity, due to both a reduction in IGF-I level and an increase in IGF-binding protein-1 level.² IGF-I is a potent mitogen for breast tissue and breast cancer cells.

By contrast, MPA and other progestins oppose the estrogen-induced reduction in IGF-I level.^2-3 This could contribute to the increase in breast cancer risk observed with the use of estrogens plus progestin as previously reported by Chlebowski et al.⁴

Carlo Campagnoli, MD
ginendocrinol@oirmsantanna.piemonte.it

Chiara Abbà, MD; Simona Ambroggio, MD; Clementina Peris, MD
Unit of Endocrinological Gynecology
Sant'Anna Gynecological Hospital
Torino, Italy

1. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291:1701-1712. FREE FULL TEXT 2. Campagnoli C, Biglia N, Cantamessa C, et al. HRT and breast cancer risk: a clue for interpreting the available data. Maturitas. 1999;33:185-190. PUBMED 3. Heald A, Selby PL, White A, Gibson JM. Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis. Am J Obstet Gynecol. 2000;183:593-600. FULL TEXT | ISI | PUBMED 4. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen-plus-progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA. 2003;289:3243-3253. FREE FULL TEXT

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2004;292:684.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Effects of Estrogen-Only Treatment in Postmenopausal Women
Herbert Kuhl
JAMA. 2004;292(6):683.
EXTRACT | FULL TEXT  

Effects of Estrogen-Only Treatment in Postmenopausal Women
Matti A. Rookus and Flora E. van Leeuwen
JAMA. 2004;292(6):683.
EXTRACT | FULL TEXT  

Effects of Estrogen-Only Treatment in Postmenopausal Women
Vicki F. Meyer
JAMA. 2004;292(6):683-684.
EXTRACT | FULL TEXT  

Effects of Estrogen-Only Treatment in Postmenopausal Women
Valerie Beral, Emily Banks, and Gillian Reeves
JAMA. 2004;292(6):684.
EXTRACT | FULL TEXT  

Effects of Estrogen-Only Treatment in Postmenopausal Women
Karla Kerlikowske and Diana L. Miglioretti
JAMA. 2004;292(6):684-685.
EXTRACT | FULL TEXT  

Effects of Estrogen-Only Treatment in Postmenopausal Women
Frank A. Perlroth
JAMA. 2004;292(6):685.
EXTRACT | FULL TEXT  

Effects of Estrogen-Only Treatment in Postmenopausal Women
Michael H. Cooper
JAMA. 2004;292(6):685.
EXTRACT | FULL TEXT  

Effects of Estrogen-Only Treatment in Postmenopausal Women—Reply
Garnet L. Anderson
JAMA. 2004;292(6):685-686.
EXTRACT | FULL TEXT  

Effects of Estrogen-Only Treatment in Postmenopausal Women
Katherine L. Brubaker
JAMA. 2004;292(6):686.
EXTRACT | FULL TEXT  

Effects of Estrogen-Only Treatment in Postmenopausal Women—Reply
Stephen B. Hulley and Deborah Grady
JAMA. 2004;292(6):686-687.
EXTRACT | FULL TEXT  

Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial
The Women's Health Initiative Steering Committee
JAMA. 2004;291(14):1701-1712.
ABSTRACT | FULL TEXT  

Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial
Rowan T. Chlebowski, Susan L. Hendrix, Robert D. Langer, Marcia L. Stefanick, Margery Gass, Dorothy Lane, Rebecca J. Rodabough, Mary Ann Gilligan, Michele G. Cyr, Cynthia A. Thomson, Janardan Khandekar, Helen Petrovitch, and Anne McTiernan
JAMA. 2003;289(24):3243-3253.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relationship between Epidemiologic Risk Factors and Hormone Receptor Expression in Ovarian Cancer: Results from the Nurses' Health Study
Hecht et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:1624-1630.
ABSTRACT | FULL TEXT